380540-38-5(2-[(3,4-dichlorobenzyl)sulfanyl]-6,6-dimethyl-3-(2-methylphenyl)-3,5,6,8-tetrahydro-4H-pyrano[4',3':4,5]thieno[2,3-d]pyrimidin-4-one)
Product Description
380540-38-5
CAS No.
380540-38-5
Chemical Name:
2-[(3,4-dichlorobenzyl)sulfanyl]-6,6-dimethyl-3-(2-methylphenyl)-3,5,6,8-tetrahydro-4H-pyrano[4',3':4,5]thieno[2,3-d]pyrimidin-4-one
CBNumber:
CB51898313
Molecular Formula:
C25H22Cl2N2O2S2
Formula Weight:
517.49
MOL File:
Mol file
2-[(3,4-dichlorobenzyl)sulfanyl]-6,6-dimethyl-3-(2-methylphenyl)-3,5,6,8-tetrahydro-4H-pyrano[4',3':4,5]thieno[2,3-d]pyrimidin-4-one Synonyms:
2-[(3,4-dichlorobenzyl)sulfanyl]-6,6-dimethyl-3-(2-methylphenyl)-3,5,6,8-tetrahydro-4H-pyrano[4',3':4,5]thieno[2,3-d]pyrimidin-4-one
4H-Pyrano[4',3':4,5]thieno[2,3-d]pyrimidin-4-one, 2-[[(3,4-dichlorophenyl)methyl]thio]-3,5,6,8-tetrahydro-6,6-dimethyl-3-(2-methylphenyl)-
2-[(3,4-dichlorobenzyl)sulfanyl]-6,6-dimethyl-3-(2-methylphenyl)-3,5,6,8-tetrahydro-4H-pyrano[4',3':4,5]thieno[2,3-d]pyrimidin-4-one
Property
Boiling point:
675.4±65.0 °C(Predicted)
Density
1.43±0.1 g/cm3(Predicted)
pka
-0.18±0.40(Predicted)
Safety
2-[(3,4-dichlorobenzyl)sulfanyl]-6,6-dimethyl-3-(2-methylphenyl)-3,5,6,8-tetrahydro-4H-pyrano[4',3':4,5]thieno[2,3-d]pyrimidin-4-one
Suppliers
Global( 3)Suppliers
Finland 2
The Netherlands 1
Global 3
Supplier
Tel
Email
Country
ProdList
Advantage
Interbioscreen Ltd.
+7 (49) 6524-0091
screen@ibscreen.chg.ru
Finland
6178
60
PHARMEKS Ltd.
+7 (495) 702-9648
sales@pharmeks.com
Finland
6350
50
Specs
+31 15 251 8111
info@specs.net
The Netherlands
6835
70
380540-38-5(2-[(3,4-dichlorobenzyl)sulfanyl]-6,6-dimethyl-3-(2-methylphenyl)-3,5,6,8-tetrahydro-4H-pyrano[4',3':4,5]thieno[2,3-d]pyrimidin-4-one)
Related Search:
2-[(3,4-dichlorobenzyl)sulfanyl]-6,6-dimethyl-3-(2-methylphenyl)-3,5,6,8-tetrahydro-4H-pyrano[4',3':4,5]thieno[2,3-d]pyrimidin-4-one
4H-Pyrano[4',3':4,5]thieno[2,3-d]pyrimidin-4-one, 2-[[(3,4-dichlorophenyl)methyl]thio]-3,5,6,8-tetrahydro-6,6-dimethyl-3-(2-methylphenyl)-
380540-38-5
C25H22Cl2N2O2S2
Copyright 2017 © ChemicalBook. All rights reserved